GHRL and pituitary gland adenoma: As proof of concept, silencing of In1-ghrelin expression significantly reduced NFPA cell viability, which is particularly relevant in this kind of pituitary adenomas since the main comorbidities are derived from tumor overgrowth and mass effects43.